Sharon Bio-Medicine Ltd-$ (Delisted) share news and announcements

BSE: 532908Pharmaceuticals & Biotechnology

Last traded ₹3.30 on 28 Mar 2019

Delisted on 20 Feb 2024.

Sharon Bio-Medicine Ltd-$ share news and announcements

831 announcements, routine notices left out, newest first. Page 10 of 17.

Jul 2016
- 16 Jul · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) .... (opens in a new tab)
Jun 2016
- 21 Jun · Board meeting
  Board of Directors of the Company at its meeting held on June 21, 2016, has: - Discussed the current financial position of the Company ....
- 21 Jun · Board meeting
  As decided in the Meeting of the Board of Directors of the Company held on June 21, 2016, for which intimation was already given to you, the Board of Directors: 1) Discussed the current financial position of the Company and decided to introduce more profitable products increase capacity utilization and get the business to move in the regulated markets specifically the United States of America. (opens in a new tab)
- 20 Jun · Legal
  Exchange had sought clarification from Sharon Bio-Medicine Limited with respect to announcement dated 12-Jan-2016 regarding the Board of Directors at their meeting held on January 12, 2016 have discussed the below:1. Closure of the subsidiary company M/s Yusur International FZE.On basis of above, the reply from the Company vide letter dated June 20, 2016 is attached. (opens in a new tab)
- 16 Jun · Board meeting
  To consider and discuss the overall financial viability of the Company. Any other matter with the permission of the Chair. (opens in a new tab)
- 16 Jun · Board Meeting on June 21, 2016
  Meeting of the Board of Directors of the Company will be held on June 21, 2016, inter alia, to consider and discuss the overall financial ....
- 15 Jun · Management
  Mr. Viral Dilip Vora, being Company Secretary in whole time in employment has resigned as a Company Secretary as well as Compliance Officer of the Company w.e.f May 31, 2016. (opens in a new tab)
- 15 Jun · Management
  Mr. Viral Dilip Vora, being Company Secretary in whole time in employment has resigned as a Company Secretary as well as Compliance Officer ....
May 2016
- 30 May · Results
  1. Standalone Financial Results for the period ended March 31, 2016 2. Consolidated Financial Results for the period ended .... (opens in a new tab)
- 30 May · Results
  Standalone & consolidated financial results along with the Auditors Report for the period ended . (opens in a new tab)
- 20 May · Board meeting
  1) To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and nine months period ended March 31, 2016. 2) Any other matter with the permission of the Chair. (opens in a new tab)
- 6 May · Shareholding for the Period Ended March 31, 2016
  Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click ....
Apr 2016
- 20 Apr · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) .... (opens in a new tab)
- 18 Apr · Disclosure
  Vide letter dated April 11, 2016 a copy of disclosure under Regulation 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 1 Apr · Disclosure
  Mohan Kala has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
Mar 2016
Feb 2016
- 15 Feb · Results
  Standalone & consolidated financial results along with the Limited Review Report for the period ended December 31, 2015. (opens in a new tab)
- 12 Feb · Results
  1. Standalone Financial Results for the period ended December 31, 2015 2. Consolidated Financial Results for the period ended .... (opens in a new tab)
- 2 Feb · Shareholding for the Period Ended December 31, 2015
  Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click ....
- 1 Feb · Board meeting
  To consider inter allia, adoption of Un-audited Financial Result for the Quarter ended on 31st December, 2015. (opens in a new tab)
Jan 2016
- 22 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation .... (opens in a new tab)
- 14 Jan · Legal
  Exchange has sought clarification from the Company with respect to announcement dated January 12, 2016, that the Board of Directors at their meeting held on January 12, 2016 have discussed the Closure of the subsidiary company M/s Yusur International FZE. On basis of above Company is required to clarify following -1. The amount and percentage of the turnover or revenue or income and net worth contributed by such entity during the last financial year; 2. Impact on the Company due to Closure.The response of the Company is awaited.
- 12 Jan · Board meeting
  Board of Directors of the Company at its meeting held on January 12, 2016, have discussed the below 1. Closure of the subsidiary ....
- 12 Jan · Board meeting
  Board of Directors at their meeting held on January 12, 2016 have discussed the below:1. Closure of the subsidiary company M/s Yusur International FZE.2. Acceptance of Resignation of Mr. Mohan Kala and Mr. Madhav Sapre from the office of Director w.e.f December 31, 2015. (opens in a new tab)
- 7 Jan · Change in Financial Year
  As per Section 2 (41) of Companies Act 2013, the financial year of a Company must be ended on 31st March every year. In respect of the same, ....
- 5 Jan · Change in Financial Year
  Company closes its financial year as on June 30, every year and to align with the provisions Section 2 (41) of Companies Act, 2013, the Company want to close the financial year on the coming March 31,2016 by preparing the Financial Statements for a period of 9 months commencing from July 01, 2015 to March 31, 2016." (opens in a new tab)
- 4 Jan · Meeting
  Voting Result of Annual General Meeting held on December 31, 2015. (opens in a new tab)
- 4 Jan · Meeting
  Proceedings of the Annual General Meeting of the Company held on December 31, 2015. (opens in a new tab)
- 2 Jan · Results
  Details of Voting results at the 26th Annual General Meeting (AGM) of the Company held on December 31, 2015, under Regulation 44(3) .... (opens in a new tab)
- 2 Jan · Meeting
  Proceedings of the 26th Annual General Meeting (AGM) of the Company held on December 31, 2015. (opens in a new tab)
Dec 2015
- 30 Dec · Results
  Standalone Financial Results for the period ended September 30, 2015, alongwith rectifying face value of Equity Share. (opens in a new tab)
- 17 Dec · Updates
  Vide letter dated December 17, 2015 regarding "Intimation for clearing National Good Laboratory Practice (GLP) Compliance Monitoring Authority (NGCMA) surveillance inspection". (opens in a new tab)
- 17 Dec
  Intimation for clearing National Good Laboratory Practice (GLP) Compliance Monitoring Authority (NGCMA) surveillance inspection (opens in a new tab)
- 15 Dec
  Sharon Bio Medicine Ltd receives USFDA approval (opens in a new tab)
- 11 Dec
  Sharon Bio Medicine Ltd. U.S. FDA News (opens in a new tab)
- 10 Dec · Meeting
  Register of Members and Share Transfer Books of the Company shall remain closed from December 25, 2015 to December 31, 2015 (both days inclusive) for the purpose of Annual General Meeting of the Company is scheduled to be held on December 31, 2015. (opens in a new tab)
- 10 Dec · Updates
  Sharon Bio Medicine Ltd. U.S. FDA News (opens in a new tab)
- 9 Dec · Disclosure
  SBICAP Trustee Company Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 9 Dec · Disclosure
  Mohan Kala has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 8 Dec · Corporate action
  Register of Members & Share Transfer Books of the Company will remain closed from December 25, 2015 to December 31, 2015 (both days inclusive) ....
- 5 Dec · Disclosure
  SBICAP Trustee Company Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 3 Dec · Disclosure
  Mohan Kala,Savita Gowda & Lalit Mishra has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 3 Dec · Disclosure
  SBICAP Trustee Company Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 3 Dec · Disclosure
  SBICAP Trustee Company Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
Nov 2015
- 10 Nov · Results
  Standalone financial results along with the Limited Review Report for the period ended 30-Sep-2015. (opens in a new tab)
- 10 Nov · Results
  Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2015. (opens in a new tab)
Oct 2015
- 29 Oct · Board meeting
  To consider inter allia, adoption of Un-audited Financial Result for the Quarter ended on September 30, 2015. (opens in a new tab)
- 21 Oct · Shareholding Pattern for September 30, 2015
  Shareholding Pattern as on September 30, 2015. (opens in a new tab)